Anti-CD22 antibody [EP498Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications )
- WB
Lab
Western blot - Anti-CD22 antibody [EP498Y] (AB33859)
Western blot : Anti-CD22 antibody [EP498Y] ab33859 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 145 kDa in Wild-type Raji cell lysates with no signal observed at this size in CD22 knockout Raji cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-CD22 antibody [EP498Y] (ab33859) at 1/1000 dilution
Lane 1:
Wild-type Raji cell lysates at 20 µg
Lane 2:
Western blot - Human CD22 knockout Raji cell line (<a href='/en-us/products/cell-lines/human-cd22-knockout-raji-cell-line-ab277160'>ab277160</a>) at 20 µg
Lane 3:
Ramos cell lysates at 20 µg
Lane 4:
A549 cell lysates at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 150 kDa
Observed band size: 145 kDa
false
- WB
Unknown
Western blot - Anti-CD22 antibody [EP498Y] (AB33859)
All lanes:
Western blot - Anti-CD22 antibody [EP498Y] (ab33859) at 1/1000 dilution
All lanes:
Raji cell lysate
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
- WB
Lab
Western blot - Anti-CD22 antibody [EP498Y] (AB33859)
Blocking and dilution buffer : 5% NFDM /TBST.
All lanes:
Western blot - Anti-CD22 antibody [EP498Y] (ab33859) at 1/5000 dilution
All lanes:
Raji whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
- WB
Lab
Western blot - Anti-CD22 antibody [EP498Y] (AB33859)
Blocking and dilution buffer : 5% NFDM /TBST.
All lanes:
Western blot - Anti-CD22 antibody [EP498Y] (ab33859) at 1/1000 dilution
Lane 1:
Rat spleen tissue lysate at 10 µg
Lane 2:
RAW264.7 whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
Related conjugates and formulations (1)
-
Anti-CD22 antibody [EP498Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD22 acts mainly as a negative regulator of B cell receptor (BCR) signaling. It is part of a complex that interacts with the BCR and other accessory molecules. CD22 helps maintain B cell tolerance by inhibiting overactive signaling and preventing autoimmune responses. By binding to sialic acid-containing glycans CD22 modulates interactions between B cells and other cells aiding in the maintenance of immune homeostasis.
Pathways
CD22 plays a critical role in the BCR signaling pathway and the regulation of phosphatidylinositol 3-kinase (PI3K) signaling. It works together with proteins like CD19 and SHP-1 that are key components of these pathways. By influencing these signaling cascades CD22 contributes to the modulation of B cell activation proliferation and apoptosis ensuring proper functioning of the immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Protein engineering, design & selection : PEDS 24:351-60 PubMed21159620
2010
Applications
Unspecified application
Species
Unspecified reactive species
Nature protocols 4:1044-63 PubMed19536272
2009
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 206:125-38 PubMed19103880
2008
Applications
Unspecified application
Species
Unspecified reactive species
Blood 111:2211-9 PubMed18025153
2007
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com